| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 03/19/2008 | CN101143865A Method for preparing ketorolac tromethamine |
| 03/19/2008 | CN101143864A Novel triazolo pyrimidine compounds |
| 03/18/2008 | US7345180 Compound inhibiting dipeptidyl peptidase IV |
| 03/18/2008 | US7345173 Work-up of the mother liquor obtained in the preparation of high-purity triethylenediamine |
| 03/18/2008 | US7345172 Intercalation compound for use in the diagnosis and detection of genetic disorders; sterically demanding nucleotide intercalating compounds and methods for detecting base pair mismatches in nucleic acid sequences |
| 03/18/2008 | US7345171 Isethionate salt of a selective CKD4 inhibitor |
| 03/18/2008 | US7345074 Derivatives of [6,7-dihydro-5H-imidazol[1,2-a]imidazole-3-sulfonylamino]-propionamide |
| 03/18/2008 | US7345064 5-(4-pyridyl)valeric acid N-[2-(1-adamantyl)ethyl]-N-pentylamide; Autoimmune diseases such as rheumatoid arthritis, allergy and diabetes |
| 03/18/2008 | US7345056 Bridged N-cyclic sulfonamido inhibitors of gamma secretase |
| 03/18/2008 | US7345049 Phenylalanine derivatives |
| 03/18/2008 | US7345048 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors |
| 03/18/2008 | US7345047 7-[7-[2-cycloalkyl]amino]-5-(propylthio)--3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]spiro[2.4]heptane-4,5,6-triol from spiro[2.4]hept-5-ene-4,7diol Diacetate and 4,6-dichloro-5-nitro-3-propylthiopyrimidine intermediates; for P2T (P2Y(ADP) or P2T(AC)) receptor antagonists; antithrombotics; unstable angina |
| 03/18/2008 | US7345046 Using quinazoline type compound ; antiproliferative agents |
| 03/18/2008 | US7345045 Pyrido-pyrimidine compounds as medicaments |
| 03/18/2008 | US7345040 Piperimido[1,2-a]piperazine-4,7diones derivatives; neurokinin (tachykinin) receptor antagonists; mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins; analgesic, neurodegenerative disorders, respiratory diseases, antiinflammatory agent, antidepressant |
| 03/18/2008 | US7345038 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 03/18/2008 | US7344751 Assembled hematin, method for forming same and method for polymerizing aromatic monomers using same |
| 03/18/2008 | CA2394120C Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it |
| 03/18/2008 | CA2359089C Novel cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions et dyeing methods |
| 03/18/2008 | CA2332853C Dry powder dispersing apparatus and methods for their use |
| 03/18/2008 | CA2324154C Fungicidal 6-(2-halo-4-alkoxyphenyl)-triazolopyrimidines |
| 03/18/2008 | CA2323839C Treatment of neuropathy |
| 03/13/2008 | WO2008030579A2 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 03/13/2008 | WO2008030119A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 03/13/2008 | WO2008030118A1 Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
| 03/13/2008 | WO2007146547A3 Piperazine enamines as antiviral agents |
| 03/13/2008 | US20080064871 Production Method of Nitrogen-Containing Fused Ring Compounds |
| 03/13/2008 | US20080064870 Pyrrolo[2,1-C][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 03/13/2008 | US20080064685 Pyrrolo[2,1-C][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 03/13/2008 | CA2663091A1 Modulators of interleukin-1 receptor-associated kinase |
| 03/13/2008 | CA2662628A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 03/13/2008 | CA2662626A1 Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
| 03/12/2008 | EP1897883A2 Cationic porphyrin derivatives as antibacterial agents |
| 03/12/2008 | EP1896478A2 Aspartyl protease inhibitors |
| 03/12/2008 | EP1896477A1 Aspartyl protease inhibitors |
| 03/12/2008 | EP1896476A2 Novel pyrazolopyrimidinone derivatives |
| 03/12/2008 | EP1896475A2 Process for the preparation of bicyclic compounds |
| 03/12/2008 | EP1896428A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 03/12/2008 | EP1896421A2 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
| 03/12/2008 | EP1896032A2 The preparation and use of compounds as protease inhibitors |
| 03/12/2008 | EP1694681B1 Pyrazolopyrimidines |
| 03/12/2008 | EP1670803B1 Certain substituted spirocyclic lactams and use thereof as pharmaceuticals |
| 03/12/2008 | EP1641799B1 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments |
| 03/12/2008 | EP1613596B1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 03/12/2008 | EP1416935B1 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives |
| 03/12/2008 | CN101142226A Tricyclic-nucleoside prodrugs for treating viral infections |
| 03/12/2008 | CN101142219A Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof |
| 03/12/2008 | CN101142218A Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 03/12/2008 | CN101142217A 咪唑并哒嗪化合物 Imidazopyridazine compounds |
| 03/12/2008 | CN101142216A Processes for preparing pyrazolo[3,4-d]pyrimidine ethers |
| 03/12/2008 | CN101139349A Heterobicyclic compounds used as fungicides |
| 03/12/2008 | CN100374442C Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 03/12/2008 | CN100374441C 2-substituted benzyl-5,7-dihydrocarbyl-3,7-dihydro pyrroline [2,3-d] pyromidine-4-one derivative ,its preparation and medicinal use |
| 03/12/2008 | CN100374438C Pre-organized tricyclic integrase inhibitor compounds |
| 03/12/2008 | CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity |
| 03/11/2008 | US7342118 Imidazole compounds for the treatment of neurodegenerative disorders |
| 03/11/2008 | US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/11/2008 | US7342028 Medical use for tachykinin antagonists |
| 03/11/2008 | US7342012 Inhibitors of αLβ2 mediated cell adhesion |
| 03/11/2008 | US7342005 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; favourable duration of action; infections |
| 03/11/2008 | US7341711 Porphyrin compounds and their use in high-field MRI |
| 03/06/2008 | WO2008027812A2 Imidazopyridine and imidazopyrimidine derivatives |
| 03/06/2008 | WO2008027284A1 Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase |
| 03/06/2008 | WO2008027220A2 Process and intermediates for the synthesis of (3-alkyl-5-piperidin-1-yl-3, 3a-dihydropyrazol0 [1, 5-a] pyrimidin-7-yl) -amino derivatives |
| 03/06/2008 | WO2008026965A1 Substituted pyrrolo[4,3-b]indoles, combinatorial and focused libraries, pharmacological composition and a method for the production and use thereof |
| 03/06/2008 | WO2008026149A1 1,4,5,6, 7,8-hexahydro-i^1s-triaza-azulene derivatives as orexin receptor antagonists |
| 03/06/2008 | WO2008025822A1 Diazolodiazine derivatives as kinase inhibitors |
| 03/06/2008 | WO2008025735A1 Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands |
| 03/06/2008 | WO2008025240A1 Composition comprising amino heterocyclic compound for hair dyeing and dyeing method |
| 03/06/2008 | WO2008014361A3 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/06/2008 | WO2008006547A3 Pyrrolopyrimidines for pharmaceutical compositions |
| 03/06/2008 | WO2008005956A3 Pyrrolotriazine kinase inhibitors |
| 03/06/2008 | WO2008003958A3 Fused pyrimido compounds |
| 03/06/2008 | US20080058543 Process for making chiral 1,4-disubstituted piperazines |
| 03/06/2008 | US20080058527 A Process for the Preparation Of 4-Amino-1-Isobutyl-1H-Imidazo[4,5-C]-Quinoline (Imiquimod) |
| 03/06/2008 | US20080058522 Process For The Preparation Of Enantiomerically Enriched Beta Amino Acid Derivatives |
| 03/06/2008 | US20080058518 Process and intermediates for the synthesis of (3-alkyl-5-piperidin-1-yl-3,3a-dihydro-pyrazolo[1,5-a]pyrimidin-7-yl)-amino derivatives and intermediates |
| 03/06/2008 | US20080058402 3-(1H-indol-2-yl)-1H-thieno[2,3-c]pyrazole-5-(N-phenoxycarboxamide); anticancer agents; protein kinase inhibitors |
| 03/06/2008 | US20080058395 Fused heterocyclic inhibitors of D-amino acid oxidase |
| 03/06/2008 | US20080058351 Novel heterobicyclic compounds |
| 03/06/2008 | US20080058350 Imidazopyridine and imidazopyrimidine derivatives |
| 03/06/2008 | US20080058349 Cognitive impairment, Alzheimer's Disease, neurodegeneration and dementia; Beta site APP Cleaving Enzyme (BACE) inhibitors; beta-secretase inhibitors; 3,3-Difluoro-8-(2',6-difluoro-3'-methoxybiphenyl-3-yl)-8-pyridin-4-yl-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-amine acetate for example |
| 03/06/2008 | US20080058341 Azaindazole compounds and methods of use |
| 03/06/2008 | US20080058325 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 03/06/2008 | US20080058319 Fused ring heterocycles as potassium channel modulators |
| 03/06/2008 | US20080058208 5,6-Cycloalkyl-7-Aminotriazolopyrimidines, their Preparation and their Use for Controlling Harmful Fungi, and Compositions Comprising these Compounds |
| 03/06/2008 | DE112006001184T5 Elektrodenkatalysator auf Porphyrin-Basis Electrode catalyst porphyrin-based |
| 03/06/2008 | CA2670271A1 Substituted oxindole derivatives, medicinal products containing them, and use thereof |
| 03/06/2008 | CA2661842A1 Serine-threonine protein kinase and parp modulators |
| 03/06/2008 | CA2661737A1 Process and intermediates for the synthesis of (3-alkyl-5-piperidin-1-yl-3,3a-dihydro-pyrazolo[1,5-a]pyrimidin-7-yl)-amino derivatives and intermediates |
| 03/06/2008 | CA2660701A1 Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase |
| 03/06/2008 | CA2659352A1 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulene derivatives as orexin receptor antagonists |
| 03/05/2008 | EP1894933A2 Compositions, methods and kits pertaining to luminescent compounds |
| 03/05/2008 | EP1894932A1 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido[2,3-d]pyrimidine derivatives and related compounds for the treatment of cancer |
| 03/05/2008 | EP1893615A1 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists |
| 03/05/2008 | EP1893577A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/05/2008 | EP1893212A2 Multicyclic compounds and methods of their use |
| 03/05/2008 | EP1732541A4 Cyclic compounds |
| 03/05/2008 | EP1697365B1 6-(2-fluoro-4-alkoxyphenyl)-triazolopyrimidines, methods for their production, their use against fungi and agents containing them |
| 03/05/2008 | EP1641800B1 Pyrazolopyrimidines |